| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Northern California Cancer Center, Union City, California 94587 [E. M. J., D. M. D., J. K.], and Sylvester Comprehensive Cancer Center and Department of Epidemiology and Public Health, University of Miami, Miami, Florida 33101 [G. G. S.]
We analyzed data from the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study to test the hypothesis that vitamin D from sunlight exposure, diet, and supplements reduces the risk of breast cancer. We identified 190 women with incident breast cancer from a cohort of 5009 white women who completed the dermatological examination and 24-h dietary recall conducted from 19711974 and who were followed up to 1992. Using Cox proportional hazards regression, we estimated relative risks (RRs) for breast cancer and 95% confidence intervals, adjusting for age, education, age at menarche, age at menopause, body mass index, alcohol consumption, and physical activity. Several measures of sunlight exposure and dietary vitamin D intake were associated with reduced risk of breast cancer, with RRs ranging from 0.670.85. The associations with vitamin D exposures, however, varied by region of residence. The risk reductions were highest for women who lived in United States regions of high solar radiation, with RRs ranging from 0.350.75. No reductions in risk were found for women who lived in regions of low solar radiation. Although limited by the relatively small size of the case population, the protective effects of vitamin D observed in this prospective study are consistent for several independent measures of vitamin D. These data support the hypothesis that sunlight and dietary vitamin D reduce the risk of breast cancer.
This article has been cited by other articles:
![]() |
D. M. Freedman, S.-C. Chang, R. T. Falk, M. P. Purdue, W.-Y. Huang, C. A. McCarty, B. W. Hollis, B. I. Graubard, C. D. Berg, and R. G. Ziegler Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 889 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Lucas, A. J McMichael, B. K Armstrong, and W. T Smith Estimating the global disease burden due to ultraviolet radiation exposure Int. J. Epidemiol., February 14, 2008; (2008) dyn017v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, and J. Chang-Claude Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study Carcinogenesis, January 1, 2008; 29(1): 93 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. John, G. G. Schwartz, J. Koo, W. Wang, and S. A. Ingles Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Breast Cancer Risk in a Multiethnic Population Am. J. Epidemiol., December 15, 2007; 166(12): 1409 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. John, J. Koo, and G. G. Schwartz Sun Exposure and Prostate Cancer Risk: Evidence for a Protective Effect of Early-Life Exposure Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1283 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Mullin and A. Dobs Vitamin D and Its Role in Cancer and Immunity: A Prescription for Sunlight Nutr Clin Pract, June 1, 2007; 22(3): 305 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin, J. E. Manson, I-M. Lee, N. R. Cook, J. E. Buring, and S. M. Zhang Intakes of Calcium and Vitamin D and Breast Cancer Risk in Women Arch Intern Med, May 28, 2007; 167(10): 1050 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Knight, M. Lesosky, H. Barnett, J. M. Raboud, and R. Vieth Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 422 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M Willis, E. M Laing, D. B Hall, D. B Hausman, and R. D Lewis A prospective analysis of plasma 25-hydroxyvitamin D concentrations in white and black prepubertal females in the southeastern United States Am. J. Clinical Nutrition, January 1, 2007; 85(1): 124 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Palmieri, T MacGregor, S Girgis, and D Vigushin Serum 25-hydroxyvitamin D levels in early and advanced breast cancer J. Clin. Pathol., December 1, 2006; 59(12): 1334 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Knight, C. M. Vachon, R. A. Vierkant, R. Vieth, J. R. Cerhan, and T. A. Sellers No association between 25-hydroxyvitamin d and mammographic density. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1988 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Skinner, D. S. Michaud, E. Giovannucci, W. C. Willett, G. A. Colditz, and C. S. Fuchs Vitamin d intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1688 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui and T. E. Rohan Vitamin d, calcium, and breast cancer risk: a review. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1427 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kemmis, S. M. Salvador, K. M. Smith, and J. Welsh Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3 J. Nutr., April 1, 2006; 136(4): 887 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Newman, K. A. Griffith, I. Jatoi, M. S. Simon, J. P. Crowe, and G. A. Colditz Meta-Analysis of Survival in African American and White American Patients With Breast Cancer: Ethnicity Compared With Socioeconomic Status J. Clin. Oncol., March 20, 2006; 24(9): 1342 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Garland, F. C. Garland, E. D. Gorham, M. Lipkin, H. Newmark, S. B. Mohr, and M. F. Holick The Role of Vitamin D in Cancer Prevention Am J Public Health, February 1, 2006; 96(2): 252 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Diorio, S. Berube, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, M. Pollak, and J. Brisson Influence of Insulin-like Growth Factors on the Strength of the Relation of Vitamin D and Calcium Intakes to Mammographic Breast Density Cancer Res., January 1, 2006; 66(1): 588 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. McCullough, C. Rodriguez, W. R. Diver, H. S. Feigelson, V. L. Stevens, M. J. Thun, and E. E. Calle Dairy, Calcium, and Vitamin D Intake and Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2898 - 2904. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rockell, T. J. Green, C. M. Skeaff, S. J. Whiting, R. W. Taylor, S. M. Williams, W. R. Parnell, R. Scragg, N. Wilson, D. Schaaf, et al. Season and Ethnicity Are Determinants of Serum 25-Hydroxyvitamin D Concentrations in New Zealand Children Aged 5-14 y J. Nutr., November 1, 2005; 135(11): 2602 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Chen, E. R. Bertone-Johnson, D. J. Hunter, W. C. Willett, and S. E. Hankinson Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2335 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Robinson Sun Exposure, Sun Protection, and Vitamin D JAMA, September 28, 2005; 294(12): 1541 - 1543. [Full Text] [PDF] |
||||
![]() |
E. R. Bertone-Johnson, W. Y. Chen, M. F. Holick, B. W. Hollis, G. A. Colditz, W. C. Willett, and S. E. Hankinson Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1991 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagpal, S. Na, and R. Rathnachalam Noncalcemic Actions of Vitamin D Receptor Ligands Endocr. Rev., August 1, 2005; 26(5): 662 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Berube, C. Diorio, B. Masse, N. Hebert-Croteau, C. Byrne, G. Cote, M. Pollak, M. Yaffe, and J. Brisson Vitamin D and Calcium Intakes from Food or Supplements and Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1653 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tseng, R. A Breslow, B. I Graubard, and R. G Ziegler Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1147 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Townsend, C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue Clin. Cancer Res., May 1, 2005; 11(9): 3579 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Souberbielle, V. Fayol, C. Sault, E. Lawson-Body, A. Kahan, and C. Cormier Assay-Specific Decision Limits for Two New Automated Parathyroid Hormone and 25-Hydroxyvitamin D Assays Clin. Chem., February 1, 2005; 51(2): 395 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Calvo, S. J Whiting, and C. N Barton Vitamin D fortification in the United States and Canada: current status and data needs Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1710S - 1716S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Welsh Vitamin D and breast cancer: insights from animal models Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1721S - 1724S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Zinser and J. Welsh Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice Carcinogenesis, December 1, 2004; 25(12): 2361 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Berube, C. Diorio, W. Verhoek-Oftedahl, and J. Brisson Vitamin D, Calcium, and Mammographic Breast Densities Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1466 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mimori, Y. Tanaka, K. Yoshinaga, T. Masuda, K. Yamashita, M. Okamoto, H. Inoue, and M. Mori Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer Ann. Onc., February 1, 2004; 15(2): 236 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kavanaugh and J. E. Green The Use of Genetically Altered Mice for Breast Cancer Prevention Studies J. Nutr., July 1, 2003; 133(7): 2404S - 2409. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Welsh, J. A. Wietzke, G. M. Zinser, B. Byrne, K. Smith, and C. J. Narvaez Vitamin D-3 Receptor as a Target for Breast Cancer Prevention J. Nutr., July 1, 2003; 133(7): 2425S - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bodiwala, C. J. Luscombe, M. E. French, S. Liu, M. F. Saxby, P. W. Jones, S. Ramachandran, A. A. Fryer, and R. C. Strange Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type Carcinogenesis, April 1, 2003; 24(4): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Freedman, M Dosemeci, and K McGlynn Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study Occup. Environ. Med., April 1, 2002; 59(4): 257 - 262. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |